Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Breast Neoplasms × CP protocol × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 8 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Salivary Gland Neoplasms 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

Cyclophosphamide 39 Docetaxel 30 Tamoxifen 29 Paclitaxel 27 Doxorubicin 26 Trastuzumab 20 Radiotherapy 18 Epirubicin 16 Letrozole 13 exemestane 11 Fluorouracil 11 Anastrozole 11 Capecitabine 10 Bevacizumab 10 Immunohistochemistry 9 Filgrastim 9 Fulvestrant 8 Methotrexate 7 Gene Expression Profiling 7 palbociclib 6 Microarray Analysis 6 Lapatinib 6 Goserelin 6 Amplified Fragment Length Polymorphism Analysis 6 Zoledronic Acid 5 Vinorelbine 5 Triptorelin Pamoate 5 Chemotherapy, Adjuvant 5 Carboplatin 5 pegfilgrastim 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03609047 2024-01-24

Appalaches

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡